Amdocs (DOX) Stock Could Be Below Fair Value After 27% Fall
Amdocs stock has had a difficult run, with the share price drifting lower over the past year even as broader valuation checks suggest it might be on the cheap side. For investors, the puzzle is whether that weak share performance is flagging deeper business concerns or simply masking an opportunity in a lowly valued telecom software provider.
- Over the past 12 months, Amdocs shares have fallen 27%, which points to a market that has grown more cautious on the business.
- The company’s ability to keep converting its telecom and media software contracts into steady cash flow can support the investment case, while any pressure on clients’ technology budgets remains a clear risk for how the stock is priced.
- Amdocs screens as undervalued on most checks, with a high value score that suggests the broader toolkit leans cheap rather than expensive for this stock.
The issue now is whether that weak recent return is a warning sign that the apparent value is a mirage or a chance to buy Amdocs at a discount before sentiment improves.
Spot potential turnarounds beyond Amdocs by scanning 33 high quality undervalued stocks that the market has pushed down despite strong underlying fundamentals.Does Amdocs Look Undervalued on Earnings?
P/E is a useful yardstick for Amdocs because earnings are a key focus for investors in mature software and services providers. On this measure, the stock trades on about 13.8x earnings, which is well below both the broader IT sector average of roughly 21.0x and the peer group on about 18.6x. That means the market is currently assigning a lower earnings multiple to Amdocs than to many similar technology businesses.
The Fair Ratio for the P/E multiple sits higher again, at about 28.7x, based on factors such as profitability, size and sector risk. Set against that benchmark, the present 13.8x looks like a steep discount, which indicates that investors are pricing in a wide margin of safety around Amdocs earnings stream.
On this earnings multiple check, Amdocs stock appears undervalued relative to both peers and the tailored fair P/E level.
See what the numbers say about this price — find out in our valuation breakdown.
The Amdocs Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the valuation puzzle on Amdocs' P/E leaves off by spelling out which paths for growth, margins and earnings would need to hold for Amdocs' shares to be worth materially more or materially less than the current price. Each scenario ties a fair value to a clear storyline about Amdocs' potential catalysts and pressure points so you can track over time which version of the future seems to be matching reality.
One of the top community narratives on Amdocs: 27% undervalued
"At the heart of its operations, Amdocs serves as a critical bridge between legacy infrastructure and modern digital requirements, supporting complex telco IT environments…"
Read one of the top narratives on Amdocs
Do you think there's more to the story for Amdocs? Head over to our Community to see what others are saying!
The Bottom Line
Amdocs screens as undervalued on earnings multiples, which points to a market that is already baking in a fair amount of caution. That discount only really pays off if cash generation from its telecom and media customers holds up and sentiment toward the sector stabilises. The key question from here is whether the current low P/E reflects overly gloomy expectations, or whether it is a fair response to the risk that client tech spending stays under pressure.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Amdocs might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com